BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28123722)

  • 1. Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.
    Wang CY; Shahi P; Huang JT; Phan NN; Sun Z; Lin YC; Lai MD; Werb Z
    Mol Clin Oncol; 2017 Jan; 6(1):7-18. PubMed ID: 28123722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.
    Jubb AM; Chalasani S; Frantz GD; Smits R; Grabsch HI; Kavi V; Maughan NJ; Hillan KJ; Quirke P; Koeppen H
    Oncogene; 2006 Jun; 25(24):3445-57. PubMed ID: 16568095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.
    Xu H; Zhao XL; Liu X; Hu XG; Fu WJ; Li Q; Wang Y; Ping YF; Zhang X; Bian XW; Yao XH
    Am J Cancer Res; 2017; 7(4):955-961. PubMed ID: 28469967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.
    Ma H; Du X; Zhang S; Wang Q; Yin Y; Qiu X; Da P; Yue H; Wu H; Xu F
    Tumour Biol; 2017 Jun; 39(6):1010428317705752. PubMed ID: 28618959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.
    Truong N; Chun SM; Kim TI; Suh YA; Jang SJ
    Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse.
    Kim SM; Kwon JE; Park JS; Seo HB; Jung KA; Moon YM; Lee J; Kwok SK; Cho ML; Park SH
    Immunol Lett; 2017 Oct; 190():26-33. PubMed ID: 28728856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.
    Shang Y; Pan Q; Chen L; Ye J; Zhong X; Li X; Meng L; Guo J; Tian Y; He Y; Chen W; Peng Z; Wang R
    Oncotarget; 2015 Oct; 6(31):30993-1006. PubMed ID: 26307678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma.
    Zheng E; Cai Z; Li W; Ni C; Fang Q
    World J Surg Oncol; 2022 Aug; 20(1):266. PubMed ID: 36008864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
    Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2.
    Zeng C; Qi G; Shen Y; Li W; Zhu Q; Yang C; Deng J; Lu W; Liu Q; Jin J
    Cancer Med; 2023 Jan; 12(1):412-424. PubMed ID: 35670012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
    Zhang D; Yoon HG; Wong J
    Mol Cell Biol; 2005 Aug; 25(15):6404-14. PubMed ID: 16024779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic cloning and localization to chromosome 11p15.5 of the human achaete-scute homolog 2 (ASCL2).
    Miyamoto T; Jinno Y; Sasaki T; Ikeda Y; Masuzaki H; Niikawa N; Ishikawa M
    Cytogenet Cell Genet; 1996; 73(4):312-4. PubMed ID: 8751384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
    Furuta M; Sakakibara-Konishi J; Kikuchi H; Yokouchi H; Nishihara H; Minemura H; Harada M; Yamazaki S; Akie K; Fujita Y; Takamura K; Kojima T; Harada T; Minami Y; Watanabe N; Oizumi S; Suzuki H; Nishimura M; Dosaka-Akita H; Isobe H;
    Oncologist; 2019 Nov; 24(11):e1172-e1179. PubMed ID: 31068386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
    Augustyn A; Borromeo M; Wang T; Fujimoto J; Shao C; Dospoy PD; Lee V; Tan C; Sullivan JP; Larsen JE; Girard L; Behrens C; Wistuba II; Xie Y; Cobb MH; Gazdar AF; Johnson JE; Minna JD
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14788-93. PubMed ID: 25267614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
    Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
    Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
    Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
    Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).
    Li J; Neumann I; Volkmer I; Staege MS
    Mol Biol Rep; 2011 Mar; 38(3):1515-21. PubMed ID: 20842449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.